Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michalina Grudzińska has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Psychobiotics in Depression and Anxiety: Efficacy, Mechanisms, and the Underestimated Risk of Antibiotic Resistance

    by Alicja Solecka, Alicja Nierychlewska, Michał Falis, Robert Bronisławski, Agata Bronisławska, Damian Stencelewski, Laura Sikorska, Magdalena Boniecka, Michalina Grudzińska, Kamila Roman

    Background. Depression and anxiety are highly prevalent, and up to one-third of depressed patients fail to achieve remission despite standard pharmacotherapy. This gap has prompted interest in the gut microbiome, via the gut - brain axis, as an adjunctive target. Psychobiotics - probiotics, prebiotics, synbiotics, and postbiotics with documented mental health effects - are promising, though their microbiological safety remains underexplored. Aim. To synthesize evidence on psychobiotic efficacy in depression and anxiety, outline gut-brain mechanisms, and highlight safety concerns regarding antimicrobial resistance transfer from bacterial formulations. Material and methods. This narrative review was based on a literature search of PubMed and Google Scholar, identifying clinical trials, meta-analyses, and studies on gut-brain communication, microbiota composition in depression/anxiety, psychobiotic efficacy, and antibiotic resistance in probiotic strains. Results. Four gut-brain pathways were identified: vagal, HPA-axis, immune, and tryptophan/serotonin routes. Depression and anxiety are linked to dysbiosis with reduced butyrate-producing and increased pro-inflammatory taxa; causality is supported by fecal transplantation studies. Probiotics show the strongest evidence for antidepressant and anxiolytic effects, especially as pharmacotherapy adjuncts. Evidence for other forms remains limited. Many probiotic strains carry mobile antibiotic resistance genes, and their use during antibiotic therapy has been linked to expansion of the gut resistome, raising safety concerns. Conclusions. Probiotics offer the most robust evidence for adjunctive treatment; other forms need further research. Strain selection should weigh both efficacy and resistance safety.

  • Open Access

    The Tattoos and the risk of health complications: a narrative review

    by Alicja Nierychlewska, Michał Falis, Alicja Solecka, Agata Bronisławska, Robert Bronisławski, Damian Stencelewski, Laura Magdalena Sikorska, Magdalena Aleksandra Boniecka, Michalina Grudzińska

    Introduction: As tattooing has become a widespread form of body modification, concerns about its health safety have grown. Tattoo inks are mixtures of organic pigments and metal compounds whose toxicological profile after intradermal application remains incompletely understood. Aim: The aim of this review was to summarise the current knowledge on the health complications of tattooing, spanning dermatological, infectious, pigment-migration and oncological aspects. A second objective was to assess the quality of the available evidence. Material and method: A narrative review of English-language literature indexed in PubMed and Google Scholar up to December 2025 was performed, including original studies, reviews, case reports and regulatory documents. Results: Cutaneous complications are best documented - early inflammatory, infectious and allergic reactions, chronic allergy (mainly to red pigment), granulomatous and sarcoidal changes, photo-induced reactions and adverse effects of laser removal. Blood-borne transmission (HBV, HCV, HIV) is linked mainly to non-professional settings; HPV, HSV and rare infective endocarditis also occur. Pigment particles, metals and titanium dioxide may migrate to regional lymph nodes, with scarce data on systemic distribution. Lymphoma findings are divergent and skin cancers within tattoos appear incidental. Conclusions: Most complications are cutaneous and mild; serious systemic and oncological consequences are rare and not confirmed as direct effects. The main gaps concern ink toxicology and long-term pigment migration, justifying further research, improved regulation and high hygienic and diagnostic standards.

  • Open Access

    Adult Circumcision for Symptomatic Phimosis in Poland: Six-Month Patient-Reported Sexual Function and Psychosocial Outcomes from a Central European Low-Circumcision Setting

    by Michał Falis, Michalina Grudzińska, Weronika Michałowska, Michał Wróbel, Julia Świechowska, Hubert Dyrszka, Michał Bałenkowski, Marcin Matuszewski, Mateusz Czajkowski

    Background: Adult circumcision is an effective surgical treatment for symptomatic phimosis, but its effects on sexual function and psychosocial outcomes remain incompletely characterized. This study aimed to assess patient-reported motivations for circumcision due to phimosis and to evaluate changes in sexual function, genital self-image, and depressive symptoms after surgery. Methods: We performed a prospective, single-center observational pre–post cohort study of adult men who underwent circumcision for symptomatic phimosis at a tertiary academic center in Poland between January 2023 and April 2025. Participants completed an author-designed questionnaire and validated patient-reported outcome measures before surgery and at six months after circumcision. The primary endpoint was the change in sexual function measured by the International Index of Erectile Function (IIEF-15). Secondary endpoints included changes in genital self-image assessed using the Male Genital Self-Image Scale (MGSIS-7), depressive symptoms measured with the Beck Depression Inventory (BDI-II), and patient-reported motivations for surgery. Paired comparisons were performed using the Wilcoxon signed-rank test. Results: A total of 148 men were included in the study. The most common reasons for surgery were pain/discomfort (58/148, 39.2%) and impaired sexual activity (51/148, 34.5%). The total IIEF-15 score increased from 46.4 ± 20.4 to 57.5 ± 21.0 (p < 0.001), with significant improvements across all domains (all p < 0.001). The total MGSIS-7 score improved from 19.9 ± 4.5 to 23.1 ± 4.0 (p < 0.001). Paired BDI-II data were available for 77 men; the total BDI-II score decreased from 1.2 ± 3.8 to 0.3 ± 1.6 (p = 0.004). Most men reported improved sexual life (127/148, 85.8%) and cosmetic satisfaction (124/148, 83.8%), and 119/148 (80.4%) reported no complications. Conclusions: Circumcision for symptomatic phimosis was associated with improved sexual function and genital self-image, alongside a statistically significant but clinically negligible decrease in subclinical depressive symptoms.

  • Open Access

    Exploratory Multi-Level Analysis of the HIF Axis in Clear-Cell Renal Cell Carcinoma and Evaluation of GN44028 as an Experimental HIF Pathway-Modulating Compound

    by Piotr M. Wierzbicki, Agnieszka Rybarczyk, Mateusz Czajkowski, Jacek Kieżun, Bartłomiej E. Kraziński, Anna Olszewska, Marzena Kogut-Wierzbicka, Zuzanna Rudaś, Aleksandra Kierczak, Karol Mitas, et al.

    Clear-cell renal cell carcinoma (ccRCC) is characterised by constitutive activation of hypoxia-inducible factors (HIFs) following VHL loss, which contributes to tumour progression and therapeutic resistance. Given the limitations of VEGFR-targeted therapies, we investigated the biological and potential therapeutic relevance of the HIF axis in ccRCC. Nuclear and cytoplasmic HIF1A and EPAS1/HIF2A expression were assessed by immunohistochemistry in tumours from 40 patients and correlated with clinicopathological parameters and cancer-specific survival. The functional effects of HIF pathway inhibitors (GN44028, KC7F2, and FM19G11) and sunitinib were analysed in VHL-mutant 786-O and VHL-wild-type Caki-1 cell lines using SRB viability assay, cell cycle analysis, wound closure assay, and RT-qPCR of HIF-related genes, with comparison to non-malignant HK-2 cells. TCGA-ccRCC data from advanced-stage patients (III–IV, n = 185) were analysed as a complementary transcriptomic context. Nuclear, but not cytoplasmic, HIF1A and EPAS1/HIF2A expression was associated with advanced stage and shorter survival in univariable analyses. GN44028 showed the most pronounced antiproliferative effect under tested conditions and was associated with broad suppression of HIF-related transcription, whereas sunitinib was associated with increased expression of selected HIF-related genes. GN44028 did not demonstrate clear selectivity over non-malignant HK-2 cells. Overall, nuclear HIF activation is associated with aggressive ccRCC biology, and broader HIF pathway modulation warrants further experimental investigation; however, the clinical findings remain exploratory, and therapeutic selectivity and translational relevance are not yet established.

  • Open Access

    Systemic Chemotherapy in Penile Squamous Cell Carcinoma: Mechanisms, Clinical Applications, and Evidence-Based Regimens

    by Michalina Grudzińska, Mateusz Czajkowski, Maciej Dolny, Marcin Matuszewski, Piotr Mieczysław Wierzbicki, Agnieszka Rybarczyk, Oliver Walther Hakenberg

    Background/Objectives: Penile squamous cell carcinoma (PSCC) is rare but aggressive. Systemic chemotherapy plays a crucial role in the management of node-positive or metastatic cases; however, the supporting evidence predominantly originates from small, non-randomized studies. This review provides a narrative analysis of the cytotoxic classes and regimens employed in PSCC and compares major clinical guidelines to facilitate informed decision-making in practice. Methods: English-language reports were identified in PubMed/Scopus/Google Scholar without date limits. Selection prioritized objective response, survival and toxicity outcomes, and guidance statements across neoadjuvant, adjuvant, and palliative settings. Results: Bleomycin-containing triplet regimens demonstrated efficacy but were associated with unacceptable pulmonary toxicity, leading to their discontinuation in clinical recommendations. Currently, cisplatin/taxane-based combinations remain fundamental in treatment protocols. The paclitaxel–ifosfamide–cisplatin (TIP) regimen achieves approximately 40–50% objective responses in phase II studies and may enable curative surgery, while taxane–cisplatin–5-fluorouracil (TPF) shows comparable efficacy with higher toxicity. For less fit patients, cisplatin–5-fluorouracil (PF) or carboplatin–taxane doublets are pragmatic alternatives. Single-agent taxanes or vinflunine offer modest second-line benefits. Although EAU–ASCO 2023, ESMO–EURACAN 2024, and NCCN v2.2025 are broadly in consensus, recommendations differ regarding eligibility thresholds and regimen preferences. Overall, the quality of the evidence remains low. Conclusions: TIP remains the reference neoadjuvant option for chemotherapy-fit patients with bulky nodal disease; doublets are reasonable when cisplatin fitness is limited; and bleomycin should be avoided. Harmonized eligibility criteria, biomarker-enriched studies, and coordinated multicenter trials are needed to improve outcomes in this rare malignancy.


  • Open Access

    Impact of device-assisted circumcision on sexual quality of life in adult males: a systematic review

    by Michalina Grudzińska, Jakub Gondek, Mateusz Czajkowski, Marcin Matuszewski

    Introduction: Device-assisted circumcision has emerged as an alternative to traditional surgical methods, offering improved safety, efficiency, and cosmetic outcomes. While its clinical benefits are documented, on analyzing the literature, no comprehensive synthesis of the impact of device-assisted circumcision on sexual quality of life in adult men, including erectile function, ejaculation control, and overall satisfaction, has been found. Objectives: To synthesize the present literature regarding the effects of device-assisted circumcision on sexual quality of life among adult male populations. Methods: A systematic review following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines was conducted. A systematic search of PubMed, EMBASE, Google Scholar, SCOPUS, EBSCO HOST, and the Cochrane Library was performed up to December 2024. The inclusion criteria encompassed prospective and retrospective clinical trials, cohort, cross-sectional, or case control, enrolling male patients ≥ 18 years old, regardless of ethnicity, marital status, and country of origin, who underwent device-assisted circumcision. The Newcastle–Ottawa Scale and Effective Public Health Practice Project Quality Assessment Tool were utilized for risk of bias assessment. Results: Literature searches identified 1643 records; 8 articles met the inclusion criteria, including 965 patients available for analysis. This cohort included 965 individuals circumcised using circumcision devices (PrePex [336]; ShangRing [297]; Alisklamp [267]; a novel disposable circumcision stitching instrument [51], and the adult circumcision template [14]). The mean age of participants ranged between 21.2 and 34.2 years. The circumcision devices either positively influence or maintain sexual satisfaction and functioning in males. Furthermore, the circumcision procedure has minimal adverse effects on erectile function, with some evidence suggesting potential improvement in the long term. Conflicting results were observed regarding sexual satisfaction and prolonged intercourse, with some studies reporting increased satisfaction and extended intercourse duration, while others found no significant changes in these aspects. Conclusion: The device-assisted circumcision demonstrates a positive influence on or maintains sexual quality of life in adult males, resulting in enhancements in erection quality, ejaculation control, duration of intercourse, and overall male satisfaction. The findings support its viability as a safe and efficacious alternative to traditional methods.